FDA Approves New Drug to Treat Niemann-Pick Disease, Type C

FDA approved Aqneursa (levacetylleucine) for the treatment of neurological symptoms associated with Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing at least 15 kg
Source: FDA Press Releases